Fullscreen Menu - Background

Subscribe to SME News Search for an article Our amazing team

Ground Floor, Suites B-D, The Maltsters,
1-2 Wetmore Road, Burton upon Trent
Staffordshire, DE14 1LS

Posted 10th April 2017

Healthcare and Life Sciences Review Taiwan’

PharmaBoardroom today releases its new 76-page Healthcare & Life Sciences Review Taiwan 2017.

Mouse Scroll AnimationScroll to keep reading
Fixed Badge - Right
healthcare and life sciences review taiwan’.

Healthcare and Life Sciences Review Taiwan’

PharmaBoardroom today releases its new 76-page Healthcare & Life Sciences Review Taiwan 2017.
This report offers companies, investors, policymakers, and stakeholders crucial insight into the rich ecosystem of pharmaceuticals, biotech, and healthcare companies on Taiwan, based on in-depth interviews conducted with leaders and pioneers across the value chain, from government representatives, global affiliate heads, and founders of innovative local SMEs.

While Taiwan’s remarkable economic growth has largely been due to a perspicacious early embrace of the semi-conductor industry; Taiwanese healthcare and life sciences, especially biotechnology, is fast gaining in importance and acquiring a global reputation. President Tsai Ing-wen herself has a background in biosciences, and many of the companies and institutions featured in the report are positioned at the vanguard of new innovations and technology in pharmaceuticals and biotech.


Featured topics include:

Taiwan’s new, life science-focused, economic model
How Taiwanese biotechs are leveraging the island’s tradition of technological excellence to drive them to new heights
The spate of recent, high-profile IPOs for Taiwanese start-ups and university spin-offs
New efforts to create innovation and knowledge-sharing clusters throughout the island
‘Five biotechs to watch’

The report features in-depth interviews with:

Chih-Kung Lee, Minister of Economic Affairs
Wu Tsung-Tsong, Minister Without Portfolio
Lin Tzou-yien, Minister of Health and Welfare (2016-17)
Carol Cheng, TRPMA
Jui-Lin Chen, Micareo
Lawrence Gan, DCB

Taiwan’s pharmaceutical and biotechnology industry can play a fundamental role in transforming Taiwan’s economy and can help Taiwan climb further up the innovation value chain” – Chih-Kung Lee, Minister of Economic Affairs

[We aim] to strengthen our innovation-centred ecosystem, build stronger bridges between our domestic industry and the world, and position Taiwan as a major hub for biomedical and biotech R&D in Asia-Pacific.” – Wu Tsung-Tsong, Minister Without Portfolio

Taiwan, the perfect country to conduct high-quality, cost-effective clinical trials, where we will be able to easily access a large patient population.” – Jonas Wang, Stemcyte

Taiwan undoubtedly holds a very experienced generics industry that has already reached international standards, including the research and manufacturing capacity required to compete on the global stage.” – Shigeo Taniuchi, Santen

Categories: Business News, News

You might also like...
Career Change Guide for 2021Business Advice8th September 2021Career Change Guide for 2021

2020 and 2021 have been years of labour market upheaval. Here is a strategic career change guide for 2021 to help you make an informed and guided decision.

How Does the Internet Influence the Way We Make Money? Trends in 2023Finance1st March 2023How Does the Internet Influence the Way We Make Money? Trends in 2023

There’s no doubt the internet has played an instrumental role in completely evolving the ways modern businesses and individuals make money. Online marketing has become the norm, and the pandemic has accelerated the shift towards e-commerce and virtual meetin

SME News Media Pack

Every quarter we offer a new issue of SME News which is published on our website, shared to our social media following and circulated to in excess of 78,000 individuals from various sectors across the UK SME marketplace.

  • TickExpand your reach.
  • TickGrow your enterprise.
  • TickSecure new clients.
View Media Pack
Media Pack - Bottom Slant Gradient
we are sme.